Adelaide: RHS Limited (ASX: RHS) (“RHS” or “the Company”) is pleased to announce that the scheme of arrangement between RHS and its shareholders (“Scheme”) has today been implemented. Implementation follows approval of the Scheme by RHS shareholders at the Scheme meeting held on 22 May 2018 and by the Federal Court of Australia on 29 […]
COPAS Vision, our newest large particle flow cytometer, adds brightfield imaging to our large particle sorting capabilities. As with our original COPAS platform of flow cytometers it provides automated high throughput analysis and sorting of viable multicellular organisms, cell clusters, bead-based libraries and other samples that are too large or too fragile for traditional flow […]
BILLERICA, Mass. — Bruker today announced the launch of the SKYSCAN™ 2214, a multiscale X-ray nano-CT (computed tomography) system with a unique X-ray source and detector geometry that generates sharper images with outstanding precision. The SKYSCAN 2214 offers unprecedented, ultra-high resolution for larger fields of view in larger objects, which makes nano-CT practical and truly useful for industrial and […]
To promote the Cancer Research Institute’s global awareness campaign, Cancer Immunotherapy Month, ACEA Biosciences will be participating in the #WearWhite campaign on June 15 and providing an Immunotherapy Research Grant to help scientists in the field of cancer research achieve their goals. As a leading innovator in the development of tools for the cancer research […]
Under this agreement, MaxCyte’s second signed with a U.S. NIH institute in the past year, the Company and the National Heart, Lung, and Blood Institute will explore development of new therapies for sickle cell disease using MaxCyte’s gene-correction platform Gaithersburg, Maryland – MaxCyte, Inc. today announces it has entered into a Cooperative Research and Development Agreement (“CRADA”) […]
New publication maps ligase fidelity profiles with single molecule real-time sequencing to enable 20+ fragment assemblies with high efficiency and accuracy IPSWICH, MA, USA — Some of today’s most exciting molecular biology engineering — including the creation of customized CRISPR/Cas9 and TALEN constructs for genome editing — are led by synthetic biologists. These scientists are […]
Utrecht, The Netherlands Continuing its customer-centric approach, and fulfilling its commitment to providing preclinical imaging systems of unmatched price/performance, MILabs has introduced its E-Class of tomographic imaging products. The E-Class imagers were specifically designed for ambitious researchers to start their research now, and who want the option to easily upgrade the same system in the […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of QT Holdings Corporation d/b/a Quad Technologies. The transaction is expected to close in early July and to be financed through available cash on hand. “We are extremely excited to welcome Quad Technologies and its line of advanced […]
Engineered Cells single-click ordering and knockout guarantee removes barriers to world-class CRISPR results REDWOOD CITY, California — Synthego, the leading genome engineering solutions company, launches its Engineered Cells Portfolio with immediate access to Knockout Clone & Pool, and Advanced Cells. The Knockout Clone and Pool products enable single-click online ordering of any human cell line with […]
Opens North America’s first BioReliance® End-to-End Biodevelopment Center to help customers with biopharmaceutical manufacturing processes Accelerates clinical development from DNA to market “Advance Biotech Grant Program” expands global biotech commitment to help awardees accelerate process set-up with MilliporeSigma services, expertise Burlington, Massachusetts — MilliporeSigma today officially opened North America’s first BioReliance® End-to-End Biodevelopment Center providing cell line development […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
